MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    The Role of Physiotherapy in Demystifying Parkinson’s Disease and Movement Disorders in Uganda.

    S. Nakisanze, J. Mutunzi, E. Jjuuko (Masaka, Uganda)

    Objective: To evaluate the effectiveness of physiotherapy interventions in improving motor function, quality of life, and stigma reduction for individuals with Parkinson’s disease in Uganda.…
  • 2025 International Congress

    Apathy and Risk of Parkinson’s Disease: A Population-Based Cohort Study

    A. Otaiku (London, United Kingdom)

    Objective: This study investigated the association between apathy and the risk of incident Parkinson's disease (PD) in community-dwelling adults. Background: Apathy is a core neuropsychiatric…
  • 2025 International Congress

    A Biomarker-Directed Approach to the Early Diagnosis of Parkinson’s Disease Using Artificial Intelligence and Machine Learning

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: The main purpose of this study was to assess how AI and ML methods integrate multiple biomarkers for diagnosing Parkinson’s Disease (PD) to improve…
  • 2025 International Congress

    Cell-type specific bidirectional modulation of STN neurons rescue Parkinsonian motor symptom.

    JH. Shin, HK. Chung, JH. Kim, JS. Yook, J. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aimed to identify the specific STN cell type and circuit responsible for alleviating parkinsonian motor symptoms through targeted neural modulation. Background: The…
  • 2025 International Congress

    Improving Motor and Non-motor Symptoms in Parkinson’s Disease: A combined Pharmaceutical and Digital Approach Targeting Parallel Neural Circuits

    A. Amedi, N. Saporta, T. Tamir, R. Sivan Hoffmann, M. Catalogna (Herzliya, Israel)

    Objective: We aimed to demonstrate the parallel neural mechanisms underlying the effects of combining standard levodopa treatment with the DopApp digital intervention on motor and…
  • 2025 International Congress

    Subthalamic β frequency oscillatory activity is modulated by self-paced wrist movement

    P. Zhuang, X. Zhao, J. Li, Y. Zhang, Y. Hu, M. Hallett, Y. Li (Beijing, China)

    Objective: To explore whether subthalamic β oscillatory neurons are associated with the initiation of voluntary movement in patients with Parkinson’s disease (PD). Background: The basal…
  • 2025 International Congress

    Striatal Dysfunction in Parkinson’s Disease Progression: A 18F-9-fluoropropyl-(+)-dihydrotetrabenazine(18F-AV133) PET Study

    X. Liu, G. Tamagnan, H. Qiao, J. Lu, C. Zhang, S. Liu (Beijing, China)

    Objective: To investigate the patterns of striatal 18F-AV133 uptake in relation to disease progression across different stages of PD and to examine its relationship with…
  • 2025 International Congress

    The Associations between Cognitive Reserve Proxies, Multimodal MRI Brain Measures and Cognition, Motor Function and Mood in Parkinson’s Disease

    I. Saywell, S. Sghirripa, A. Walls, A. Dwyer, B. Child, J. Salamon, S. Hansch-Maher, L. Collins-Praino, M. Jenkinson, I. Baetu (Adelaide, Australia)

    Objective: This study aimed to use multimodal MRI to explore the relative importance of cognitive reserve (CR) proxies, compared to CR- and Parkinson’s disease (PD)-related…
  • 2025 International Congress

    Brain hemodynamic responses to a motor control paradigm in younger and older adults, and people with Parkinson’s Disease: An fNIRS mediated feasibility study.

    M. Bjalme-Evans, K. Heffernan, D. Wani, S. Leung, J. Carter, A. Bowden, A. Raghunathan, L. Quinn (New York, USA)

    Objective: This study aims to investigate the use of fNIRS in measuring the hemodynamic response of the brain during motor control tasks of increasing complexity…
  • 2025 International Congress

    Assessing Genome-wide Genetic Risk for Parkinson’s Disease Age at Onset in European Sub-Populations: from the Global Parkinson’s Genetics Program

    GP2. Parkinson'S_genetics_program (Bethesda, USA)

    Objective: To identify the genetic determinants of Parkinson’s disease (PD) age at onset (AAO) within and across genetically determined European ancestries (European, Ashkenazi Jewish, Finnish,…
  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley